SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030067
Filing Date
2019-08-07
Accepted
2019-08-07 16:11:39
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20190630.htm 10-Q 2095232
2 EX-31.1 sndx-ex311_8.htm EX-31.1 10281
3 EX-31.2 sndx-ex312_6.htm EX-31.2 10734
4 EX-32.1 sndx-ex321_7.htm EX-32.1 11878
  Complete submission text file 0001564590-19-030067.txt   7833632

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sndx-20190630.xml EX-101.INS 1959189
6 XBRL TAXONOMY EXTENSION SCHEMA sndx-20190630.xsd EX-101.SCH 51821
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20190630_cal.xml EX-101.CAL 45925
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20190630_def.xml EX-101.DEF 167868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20190630_lab.xml EX-101.LAB 370659
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20190630_pre.xml EX-101.PRE 278509
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 191005578
SIC: 2834 Pharmaceutical Preparations